We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

E-mails Question FDA Review Process For Ketek

Law360 (July 19, 2006, 12:00 AM EDT) -- Several recently uncovered e-mails have exposed concern by Food and Drug Administration officials that the agency’s approval of a bronchitis treatment marketed by Sanofi-Aventis was a potentially lethal mistake.

An FDA...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.